ADULT AIDS CLINICAL RESEARCH
ADULT AIDS CLINICAL RESEARCH
批准号:
3746781
负责人:
MICHAEL M LEDERMAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AIDS AIDS dementia complex AIDS therapy HIV infections Hispanic Americans antiAIDS agent brain metabolism calcium channel blockers clinical trials electrophysiology evoked potentials female hemophilia As human subject human therapy evaluation infection related neoplasm /cancer intravenous drug abuse medical complication medical outreach /case finding microorganism disease chemotherapy neurology neuropsychological tests opportunistic infections positron emission tomography
中文摘要
凯斯西储大学艾滋病临床试验部门为5.4
占俄亥俄州艾滋病病例47%的百万人口地区。这
这一节为继续维持现有的反腐败联盟提供了理由
是一项重要的社区资源,也是
全国ACTG的努力。
这家位于克利夫兰和托莱多的ACTU在成本效益方面有着很强的记录
纳入ACTG试验的患者,包括未得到充分服务的少数群体。至
为少数群体提供额外的试验机会,第二个ACTU
将在县MetroHealth医疗中心设立子单位
克利夫兰西区的一家医院,为大型非裔美国人和
西班牙裔社区。
主要的ACTU及其两个附属单位是三个最大的艾滋病毒护理提供者
在北俄亥俄州,每个人都提供护理,而不考虑支付能力。
作为艾滋病毒护理提供者和艾滋病研究人员,这些单位整合了
临床护理和临床研究及其工作人员赢得了信任
以及他们病人和社区的信心。与民众进行接触
目前在ACTG试验中代表性不足是ACTU的一个主要组成部分
活动。这些单位预计每年至少有140名患者应得
到ACTG试验。
英文摘要
The Case Western Reserve University AIDS Clinical Trials Unit serves a 5.4
million population region that accounts for 47% of Ohio's AIDS cases. This
section provides rationale for the continuation of an established ACTU that
is a vital community resource and is an important contributor to the
national ACTG effort.
This Cleveland and Toledo-based ACTU has a strong record of cost efficient
accrual of patients including underserved minorities into ACTG trials. To
provide additional trials access to minority populations, a second ACTU
subunit will be established at MetroHealth Medical Center, a county
hospital on Cleveland's West Side that serves large African-American and
Hispanic communities.
The main ACTU and its two subunits are the three largest HIV care providers
in Northern Ohio and each provides care without regard to ability to pay.
As both HIV care providers and AIDS researchers, these units integrate
clinical care and clinical research and their staff have earned the trust
and confidence of their patients and communities. Outreach to populations
currently under-represented in ACTG trials is a major component of ACTU
activities. These Units project a minimum accrual of 140 patients per year
to ACTG trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOLOGY AGENDA
-
批准号:5205123
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:--
CORE--ADVANCED TECHNOLOGY LABORATORIES
-
批准号:5205127
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:--
ADULT AIDS CLINICAL RESEARCH
-
批准号:3727024
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
RIFAMPIN, CIPROFLAXACIN, CLOFAZIMINE, ETHAMBUTOL, & AMIKACIN IN HIV+ INDIVIDUALS
-
批准号:3785436
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
PROCYSTEINE IN PATIENTS INFECTED WITH HIV--EFFECTS ON LEVELS OF GLUTATHIONE
-
批准号:3785439
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
OUTCOMES COMMITTEE AGENDA
-
批准号:5205125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:--
PHARMACOKINETICS OF ORAL PROCYSTEINE EFFECTS ON GLUTATHIONE
-
批准号:3785442
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
ADULT AIDS CLINICAL RESEARCH
-
批准号:3791120
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
RIFAMPIN, CIPROFLAXACIN, CLOFAZIMINE, ETHAMBUTOL, & AMIKACIN IN HIV+ INDIVIDUALS
-
批准号:3849178
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
PROCYSTEINE TM TO PLACEBO IN HIV INFECTED PTS TAKING ANTIRETROVIRAL NUCLEOSIDE
-
批准号:3763392
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
CLINICAL TRIALS STUDY GROUP
-
批准号:3818788
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
CLINICAL TRIALS STUDY GROUP
-
批准号:3810134
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
CLINICAL TRIALS STUDY GROUP
-
批准号:3822578
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
IV PROCYSTEINE IN PATIENTS INFECTED WITH HIV--EFFECTS ON LEVELS OF GLUTATHIONE
-
批准号:3785472
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
ORAL RO 24-7429 (TAT ANTAGONIST) IN PATIENTS WITH HIV INFECTION
-
批准号:3785487
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
NEUROLOGY AGENDA
-
批准号:5205121
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:--
ACTG STUDY IN AIDS--2'3'DIDEOXYINOSINE & AZT FOR AIDS/ARC PATIENTS ON AZT THERAPY
-
批准号:3884547
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
ADULT AIDS CLINICAL RESEARCH
-
批准号:3769045
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:
WOMEN'S HEALTH AGENDA
-
批准号:5205124
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:--
COMPLICATIONS OF HIV DISEASE AGENDA
-
批准号:5205120
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL M LEDERMAN
-
依托单位:--
海外基金